Paclitaxel-Coated Balloon Versus Zotarolimus-Eluting Stent for Treatment of De Novo Coronary Artery Lesions
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 370 participants.
Also called NCT05209412
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 370 participants
- Sponsor
- Registry
-
NCT05209412
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT05209412. Randomized; no masking; primary purpose treatment. Start 2022-02-01 (actual); primary completion 2024-02-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Paclitaxel-Coated Balloon Versus Zotarolimus-Eluting Stent for Treatment of De Novo Coronary Artery Lesions
- Acronym
- CAGE-FREEIII
- Condition
- De Novo Stenosis
- Condition
- Coronary Artery Disease
- Condition
- Percutaneous Coronary Intervention
- Intervention (Device)
- Lepu Paclitaxel coated balloon
- Intervention (Device)
- Resolute Integrity Zotarolimus eluting stents
- Intervention (Drug)
- Aspirin
- Intervention (Drug)
- Ticagrelor
- Intervention (Drug)
- Clopidogrel
- Lead sponsor
- Xijing Hospital
Record details
- Record id
cardio:ct-nct05209412- Content hash
fcdc328ef75a9ffbfb2dd20ae73946c30c400a54016036d3f50b6ec53f5e4e78